Cures Bill Seeks $90M For FDA Over 5 Years For 3 Specific Provisions

The latest version of 21st Century Cures legislation unanimously passed by the Energy and Commerce Committee Thursday (May 21) seeks $90 million over five years in additional funding for FDA for three specific provisions that require: the qualification of biomarkers and other drug development tools; collection of evidence from clinical experience using the Sentinel System; and grants for studying and recommending improvements to the process of continuous manufacturing of drugs and biologic products. The bill passed by the Committee Thursday...